Global Anlotinib Market Growth (Status and Outlook) 2022-2028
- LP 4768493
- 61 Pages
- January 2022
- Pharmaceuticals
The United States Anlotinib market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Anlotinib market, reaching US$ million by the year 2028. As for the Europe Anlotinib landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Anlotinib players cover CHIA TAI TIANQING, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Anlotinib market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
8mg Capsules
10mg Capsules
12mg Capsules
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Non-small Cell Lung Cancer
Ovarian Cancer
Soft Tissue Sarcoma
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
CHIA TAI TIANQING
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anlotinib Market Size 2017-2028
2.1.2 Anlotinib Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Anlotinib Segment by Type
2.2.1 8mg Capsules
2.2.2 10mg Capsules
2.2.3 12mg Capsules
2.3 Anlotinib Market Size by Type
2.3.1 Anlotinib Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Anlotinib Market Size Market Share by Type (2017-2022)
2.4 Anlotinib Segment by Application
2.4.1 Non-small Cell Lung Cancer
2.4.2 Ovarian Cancer
2.4.3 Soft Tissue Sarcoma
2.4.4 Other
2.5 Anlotinib Market Size by Application
2.5.1 Anlotinib Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Anlotinib Market Size Market Share by Application (2017-2022)
3 Anlotinib Market Size by Player
3.1 Anlotinib Market Size Market Share by Players
3.1.1 Global Anlotinib Revenue by Players (2020-2022)
3.1.2 Global Anlotinib Revenue Market Share by Players (2020-2022)
3.2 Global Anlotinib Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Anlotinib by Regions
4.1 Anlotinib Market Size by Regions (2017-2022)
4.2 Americas Anlotinib Market Size Growth (2017-2022)
4.3 APAC Anlotinib Market Size Growth (2017-2022)
4.4 Europe Anlotinib Market Size Growth (2017-2022)
4.5 Middle East & Africa Anlotinib Market Size Growth (2017-2022)
5 Americas
5.1 Americas Anlotinib Market Size by Country (2017-2022)
5.2 Americas Anlotinib Market Size by Type (2017-2022)
5.3 Americas Anlotinib Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anlotinib Market Size by Region (2017-2022)
6.2 APAC Anlotinib Market Size by Type (2017-2022)
6.3 APAC Anlotinib Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Anlotinib by Country (2017-2022)
7.2 Europe Anlotinib Market Size by Type (2017-2022)
7.3 Europe Anlotinib Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Anlotinib by Region (2017-2022)
8.2 Middle East & Africa Anlotinib Market Size by Type (2017-2022)
8.3 Middle East & Africa Anlotinib Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Anlotinib Market Forecast
10.1 Global Anlotinib Forecast by Regions (2023-2028)
10.1.1 Global Anlotinib Forecast by Regions (2023-2028)
10.1.2 Americas Anlotinib Forecast
10.1.3 APAC Anlotinib Forecast
10.1.4 Europe Anlotinib Forecast
10.1.5 Middle East & Africa Anlotinib Forecast
10.2 Americas Anlotinib Forecast by Country (2023-2028)
10.2.1 United States Anlotinib Market Forecast
10.2.2 Canada Anlotinib Market Forecast
10.2.3 Mexico Anlotinib Market Forecast
10.2.4 Brazil Anlotinib Market Forecast
10.3 APAC Anlotinib Forecast by Region (2023-2028)
10.3.1 China Anlotinib Market Forecast
10.3.2 Japan Anlotinib Market Forecast
10.3.3 Korea Anlotinib Market Forecast
10.3.4 Southeast Asia Anlotinib Market Forecast
10.3.5 India Anlotinib Market Forecast
10.3.6 Australia Anlotinib Market Forecast
10.4 Europe Anlotinib Forecast by Country (2023-2028)
10.4.1 Germany Anlotinib Market Forecast
10.4.2 France Anlotinib Market Forecast
10.4.3 UK Anlotinib Market Forecast
10.4.4 Italy Anlotinib Market Forecast
10.4.5 Russia Anlotinib Market Forecast
10.5 Middle East & Africa Anlotinib Forecast by Region (2023-2028)
10.5.1 Egypt Anlotinib Market Forecast
10.5.2 South Africa Anlotinib Market Forecast
10.5.3 Israel Anlotinib Market Forecast
10.5.4 Turkey Anlotinib Market Forecast
10.5.5 GCC Countries Anlotinib Market Forecast
10.6 Global Anlotinib Forecast by Type (2023-2028)
10.7 Global Anlotinib Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 CHIA TAI TIANQING
11.1.1 CHIA TAI TIANQING Company Information
11.1.2 CHIA TAI TIANQING Anlotinib Product Offered
11.1.3 CHIA TAI TIANQING Anlotinib Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 CHIA TAI TIANQING Main Business Overview
11.1.5 CHIA TAI TIANQING Latest Developments
12 Research Findings and Conclusion
Table 1. Anlotinib Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of 8mg Capsules
Table 3. Major Players of 10mg Capsules
Table 4. Major Players of 12mg Capsules
Table 5. Anlotinib Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Anlotinib Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Anlotinib Market Size Market Share by Type (2017-2022)
Table 8. Anlotinib Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Anlotinib Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Anlotinib Market Size Market Share by Application (2017-2022)
Table 11. Global Anlotinib Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Anlotinib Revenue Market Share by Player (2020-2022)
Table 13. Anlotinib Key Players Head office and Products Offered
Table 14. Anlotinib Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Anlotinib Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Anlotinib Market Size Market Share by Regions (2017-2022)
Table 19. Americas Anlotinib Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Anlotinib Market Size Market Share by Country (2017-2022)
Table 21. Americas Anlotinib Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Anlotinib Market Size Market Share by Type (2017-2022)
Table 23. Americas Anlotinib Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Anlotinib Market Size Market Share by Application (2017-2022)
Table 25. APAC Anlotinib Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Anlotinib Market Size Market Share by Region (2017-2022)
Table 27. APAC Anlotinib Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Anlotinib Market Size Market Share by Type (2017-2022)
Table 29. APAC Anlotinib Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Anlotinib Market Size Market Share by Application (2017-2022)
Table 31. Europe Anlotinib Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Anlotinib Market Size Market Share by Country (2017-2022)
Table 33. Europe Anlotinib Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Anlotinib Market Size Market Share by Type (2017-2022)
Table 35. Europe Anlotinib Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Anlotinib Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Anlotinib Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Anlotinib Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Anlotinib Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Anlotinib Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Anlotinib Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Anlotinib Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Anlotinib
Table 44. Key Market Challenges & Risks of Anlotinib
Table 45. Key Industry Trends of Anlotinib
Table 46. Global Anlotinib Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Anlotinib Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Anlotinib Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Anlotinib Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Anlotinib Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Anlotinib Market Size Market Share Forecast by Application (2023-2028)
Table 52. CHIA TAI TIANQING Details, Company Type, Anlotinib Area Served and Its Competitors
Table 53. CHIA TAI TIANQING Anlotinib Product Offered
Table 54. CHIA TAI TIANQING Anlotinib Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. CHIA TAI TIANQING Main Business
Table 56. CHIA TAI TIANQING Latest Developments
List of Figures
Figure 1. Anlotinib Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Anlotinib Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Anlotinib Market Size Market Share by Type in 2021
Figure 7. Anlotinib in Non-small Cell Lung Cancer
Figure 8. Global Anlotinib Market: Non-small Cell Lung Cancer (2017-2022) & ($ Millions)
Figure 9. Anlotinib in Ovarian Cancer
Figure 10. Global Anlotinib Market: Ovarian Cancer (2017-2022) & ($ Millions)
Figure 11. Anlotinib in Soft Tissue Sarcoma
Figure 12. Global Anlotinib Market: Soft Tissue Sarcoma (2017-2022) & ($ Millions)
Figure 13. Anlotinib in Other
Figure 14. Global Anlotinib Market: Other (2017-2022) & ($ Millions)
Figure 15. Global Anlotinib Market Size Market Share by Application in 2021
Figure 16. Global Anlotinib Revenue Market Share by Player in 2021
Figure 17. Global Anlotinib Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Anlotinib Market Size 2017-2022 ($ Millions)
Figure 19. APAC Anlotinib Market Size 2017-2022 ($ Millions)
Figure 20. Europe Anlotinib Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Anlotinib Market Size 2017-2022 ($ Millions)
Figure 22. Americas Anlotinib Value Market Share by Country in 2021
Figure 23. Americas Anlotinib Consumption Market Share by Type in 2021
Figure 24. Americas Anlotinib Market Size Market Share by Application in 2021
Figure 25. United States Anlotinib Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Anlotinib Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Anlotinib Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Anlotinib Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Anlotinib Market Size Market Share by Region in 2021
Figure 30. APAC Anlotinib Market Size Market Share by Application in 2021
Figure 31. China Anlotinib Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Anlotinib Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Anlotinib Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Anlotinib Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Anlotinib Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Anlotinib Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Anlotinib Market Size Market Share by Country in 2021
Figure 38. Europe Anlotinib Market Size Market Share by Type in 2021
Figure 39. Europe Anlotinib Market Size Market Share by Application in 2021
Figure 40. Germany Anlotinib Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Anlotinib Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Anlotinib Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Anlotinib Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Anlotinib Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Anlotinib Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Anlotinib Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Anlotinib Market Size Market Share by Application in 2021
Figure 48. Egypt Anlotinib Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Anlotinib Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Anlotinib Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Anlotinib Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Anlotinib Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Anlotinib Market Size 2023-2028 ($ Millions)
Figure 54. APAC Anlotinib Market Size 2023-2028 ($ Millions)
Figure 55. Europe Anlotinib Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Anlotinib Market Size 2023-2028 ($ Millions)
Figure 57. United States Anlotinib Market Size 2023-2028 ($ Millions)
Figure 58. Canada Anlotinib Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Anlotinib Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Anlotinib Market Size 2023-2028 ($ Millions)
Figure 61. China Anlotinib Market Size 2023-2028 ($ Millions)
Figure 62. Japan Anlotinib Market Size 2023-2028 ($ Millions)
Figure 63. Korea Anlotinib Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Anlotinib Market Size 2023-2028 ($ Millions)
Figure 65. India Anlotinib Market Size 2023-2028 ($ Millions)
Figure 66. Australia Anlotinib Market Size 2023-2028 ($ Millions)
Figure 67. Germany Anlotinib Market Size 2023-2028 ($ Millions)
Figure 68. France Anlotinib Market Size 2023-2028 ($ Millions)
Figure 69. UK Anlotinib Market Size 2023-2028 ($ Millions)
Figure 70. Italy Anlotinib Market Size 2023-2028 ($ Millions)
Figure 71. Russia Anlotinib Market Size 2023-2028 ($ Millions)
Figure 72. Spain Anlotinib Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Anlotinib Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Anlotinib Market Size 2023-2028 ($ Millions)
Figure 75. Israel Anlotinib Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Anlotinib Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Anlotinib Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
